Scandinavian Diverticulitis Trial (SCANDIV)
Scandinavian Diverticulitis Trial. Laparoscopic Lavage vs Primary Resection as Treatment for Perforated Diverticulitis. A Randomized Prospective Multicenter Trial
Sponsor: Centrallasarettet Västerås
This NA trial investigates Diverticulitis and is currently completed. Centrallasarettet Västerås leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Jan 2022 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centrallasarettet Västerås
- Diakonhjemmet Hospital
- Eskilstuna Lasarettet
- Haukeland University Hospital
- Helse Nord
- Helse Nord-Trøndelag HF
- Helse Nordmøre og Romsdal
- Helse Stavanger HF
- Helsingborgs Hospital
- Karolinska University Hospital
- Skane University Hospital
- Sykehuset Asker og Baerum
- Sykehuset Buskerud HF
- Sykehuset Innlandet HF
- Sykehuset Ostfold
- Ullevaal University Hospital
- University Hospital, Akershus
- University Hospital, Linkoeping
- Uppsala University Hospital
- Vrinnevisjukhuset i Norrköping
For direct contact, visit the study record on ClinicalTrials.gov .